FOSTER CITY, CA--(Marketwire - December 10, 2010) - Applikon Biotechnology has established an agreement with InDevR, Inc. to distribute the ViroCyt™ Virus Counter®, a novel, easy-to-use instrument for rapid quantification of virus samples.
The Virus Counter provides a direct measurement of virus particle concentration within minutes. Unlike conventional plaque titer assays, which take days to complete, the Virus Counter provides accurate and quantitative results in less than 10 minutes. The instrument requires minimal technical training and its small footprint makes it an easy addition to the lab.
The Virus Counter is a unique, "personal" flow cytometer designed specifically for virus quantification. Similar to virus concentration determined by transmission electron microscopy (TEM), the Virus Counter provides a measurement of the total number of virus particles per mL (vp/mL). Unlike TEM however, the assay can be completed in minutes by lab personnel at a per sample cost ~1,000x lower than for TEM.
John Chory, President of Applikon Biotechnology, commented, "The Virus Counter is an important and exciting addition to Applikon's portfolio of upstream products. The Virus Counter is a significant innovation that dramatically changes the way researchers quantify virus samples. Analysis that used to take days to complete now takes minutes and can done be for a small fraction of the cost of alternative methods. Applikon is pleased to work with InDevR to bring this key product to market. InDevR has an innovative approach to process challenges and this fits in nicely with Applikon's goal of providing novel solutions for its customers."
Dr. Kathy Rowlen, CEO of InDevR, states, "We are tremendously excited to be working with Applikon to distribute our Virus Counter. InDevR's strong product development capability is complemented by Applikon's 25 year history supplying and supporting innovative products used in biotechnology laboratories. Applikon has a strong technical service and customer support capability that adds significant value to our relationship and will ensure that end-users will be well supported."
Applikon Biotechnology, Inc. is a US based corporation and is a subsidiary of Applikon Biotechnology, B.V., a privately owned Dutch company that develops, manufactures and supplies bioreactor systems and related ancillary products for research and production. Applikon Biotechnology, Inc. was founded in 1983; Applikon is a global leader in providing a broad range of products in cell cultivation and analysis solutions for R&D, Pilot, and cGMP applications. Applikon Biotechnology, Inc. is headquartered in Foster City, CA. Applikon Biotechnology, B.V. is located in Schiedam, the Netherlands.
InDevR, Inc. is a US corporation established in 2003 and based in Boulder, CO. InDevR develops breakthrough life science instrumentation and assays for scientists and researchers. The company's talented science and engineering staff understand the issues associated with virus quantification and pathogen detection. This know-how drives the development of straightforward and reliable new analytical tools to streamline microbiological analysis.